{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T05:10:25Z","timestamp":1778908225887,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,23]],"date-time":"2024-03-23T00:00:00Z","timestamp":1711152000000},"content-version":"vor","delay-in-days":82,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011645","name":"Kaohsiung Medical University Chung-Ho Memorial Hospital","doi-asserted-by":"publisher","award":["KMUHI11-MI09"],"award-info":[{"award-number":["KMUHI11-MI09"]}],"id":[{"id":"10.13039\/501100011645","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior Reports"],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/j.ebr.2024.100662","type":"journal-article","created":{"date-parts":[[2024,3,24]],"date-time":"2024-03-24T19:53:32Z","timestamp":1711310012000},"page":"100662","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Trends of anti-seizure medication prescribing pattern in traumatic brain injury patients for the prevention of posttraumatic seizure in Taiwan"],"prefix":"10.1016","volume":"26","author":[{"given":"Hsin-Tien","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fen-Fen","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sui-Sum","family":"Kung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shang-Jyh","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1565-2936","authenticated-orcid":false,"given":"Kun-Pin","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebr.2024.100662_b0005","unstructured":"Centers for Disease Control and Prevention. Report to Congress on Traumatic Brain Injury in the United States: Epidemiology and Rehabilitation 2015. Available from: https:\/\/www.cdc.gov\/traumaticbraininjury\/pubs\/congress_epi_rehab.html."},{"issue":"11","key":"10.1016\/j.ebr.2024.100662_b0010","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/j.apmr.2010.05.017","article-title":"Position statement: definition of traumatic brain injury","volume":"91","author":"Menon","year":"2010","journal-title":"Arch Phys Med Rehabil"},{"issue":"10","key":"10.1016\/j.ebr.2024.100662_b0015","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S1474-4422(17)30279-X","article-title":"The chronic and evolving neurological consequences of traumatic brain injury","volume":"16","author":"Wilson","year":"2017","journal-title":"Lancet Neurol"},{"issue":"s10","key":"10.1016\/j.ebr.2024.100662_b0020","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1528-1157.44.s10.4.x","article-title":"Epidemiology of posttraumatic epilepsy: a critical review","volume":"44","author":"Frey","year":"2003","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.ebr.2024.100662_b0025","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.nec.2016.06.001","article-title":"Seizures and the role of anticonvulsants after traumatic brain injury","volume":"27","author":"Zimmermann","year":"2016","journal-title":"Neurosurg Clin N Am"},{"key":"10.1016\/j.ebr.2024.100662_b0030","article-title":"Pharmacological treatments for preventing epilepsy following traumatic head injury","volume":"8","author":"Thompson","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ebr.2024.100662_b0035","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.wneu.2018.11.076","article-title":"The effectiveness of antiepileptic medications as prophylaxis of Early seizure in patients with traumatic brain injury Compared with placebo or no treatment: a systematic review and meta-analysis","volume":"122","author":"Wat","year":"2019","journal-title":"World Neurosurg"},{"issue":"1","key":"10.1016\/j.ebr.2024.100662_b0040","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1227\/NEU.0000000000001432","article-title":"Guidelines for the Management of Severe Traumatic Brain Injury","volume":"80","author":"Carney","year":"2017","journal-title":"Fourth Edition Neurosurgery"},{"key":"10.1016\/j.ebr.2024.100662_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2020.111393","article-title":"Phenytoin - an anti-seizure drug: overview of its chemistry, pharmacology and toxicology","volume":"142","author":"Patocka","year":"2020","journal-title":"Food Chem Toxicol"},{"issue":"2","key":"10.1016\/j.ebr.2024.100662_b0050","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jsps.2022.12.001","article-title":"A comprehensive review on pharmacological applications and drug-induced toxicity of valproic acid","volume":"31","author":"Safdar","year":"2023","journal-title":"Saudi Pharm J"},{"issue":"6","key":"10.1016\/j.ebr.2024.100662_b0055","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1007\/s00415-020-09769-5","article-title":"Impact of anti-epileptic drug choice on discharge in acute traumatic brain injury patients","volume":"267","author":"Harris","year":"2020","journal-title":"J Neurol"},{"issue":"2","key":"10.1016\/j.ebr.2024.100662_b0060","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s12028-009-9304-y","article-title":"Prospective, randomized, single-blinded comparative trial of intravenous levetiracetam versus phenytoin for seizure prophylaxis","volume":"12","author":"Szaflarski","year":"2010","journal-title":"Neurocrit Care"},{"issue":"3","key":"10.1016\/j.ebr.2024.100662_b0065","first-page":"455","article-title":"Comparison of efficacy of phenytoin and Levetiracetam for prevention of Early post traumatic seizures","volume":"28","author":"Khan","year":"2016","journal-title":"J Ayub Med Coll Abbottabad"},{"issue":"3","key":"10.1016\/j.ebr.2024.100662_b0070","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00701-018-3683-9","article-title":"Pharmacological management of post-traumatic seizures in adults: current practice patterns in the UK and the Republic of Ireland","volume":"161","author":"Mee","year":"2019","journal-title":"Acta Neurochir"},{"issue":"10","key":"10.1016\/j.ebr.2024.100662_b0075","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1097\/JCMA.0000000000000414","article-title":"Preventing epilepsy after traumatic brain injury: a propensity score analysis","volume":"83","author":"Liou","year":"2020","journal-title":"J Chin Med Assoc"},{"key":"10.1016\/j.ebr.2024.100662_b0080","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2147\/CLEP.S196293","article-title":"Taiwan's National Health Insurance Research Database: past and future","volume":"11","author":"Hsieh","year":"2019","journal-title":"Clin Epidemiol"},{"issue":"4","key":"10.1016\/j.ebr.2024.100662_b0085","first-page":"188","article-title":"Charlson comorbidity index: ICD-9 update and ICD-10 translation","volume":"12","author":"Glasheen","year":"2019","journal-title":"Am Health Drug Benefits"},{"issue":"1","key":"10.1016\/j.ebr.2024.100662_b0090","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13054-018-2000-6","volume":"22","author":"Huijben","year":"2018","journal-title":"Crit Care"},{"issue":"23","key":"10.1016\/j.ebr.2024.100662_b0095","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1212\/WNL.0b013e31823b478c","article-title":"Severe cutaneous adverse reactions to antiepileptic drugs in asians","volume":"77","author":"Yang","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.ebr.2024.100662_b0100","article-title":"An updated review of genetic associations with severe adverse drug reactions: translation and implementation of Pharmacogenomic testing in clinical Practice","volume":"13","author":"Wang","year":"2022","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.ebr.2024.100662_b0105","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2217\/pgs-2021-0126","article-title":"The association between HLA-B*15:02 and phenytoin-induced severe cutaneous adverse reactions: a meta-analysis","volume":"23","author":"Phung","year":"2022","journal-title":"Pharmacogenomics"},{"issue":"5","key":"10.1016\/j.ebr.2024.100662_b0110","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1001\/jama.2014.7859","article-title":"Genetic variants associated with phenytoin-related severe cutaneous adverse reactions","volume":"312","author":"Chung","year":"2014","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.ebr.2024.100662_b0115","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.jfma.2021.09.025","article-title":"Analysis of severe cutaneous adverse reactions (SCARs) in Taiwan drug-injury relief system: 18-year results","volume":"121","author":"Huang","year":"2022","journal-title":"J Formos Med Assoc"},{"issue":"5","key":"10.1016\/j.ebr.2024.100662_b0120","doi-asserted-by":"crossref","DOI":"10.3390\/jpm11050383","article-title":"Genetic determinants in HLA and cytochrome P450 genes in the risk of aromatic antiepileptic-induced severe cutaneous adverse reactions","volume":"11","author":"Ahmed","year":"2021","journal-title":"J Pers Med"},{"key":"10.1016\/j.ebr.2024.100662_b0125","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.seizure.2023.03.017","article-title":"Levetiracetam, from broad-spectrum use to precision prescription: a narrative review and expert opinion","volume":"107","author":"Celdran de Castro","year":"2023","journal-title":"Seizure"},{"key":"10.1016\/j.ebr.2024.100662_b0130","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.yebeh.2017.08.039","article-title":"Psychiatric and behavioral side effects of antiepileptic drugs in adults with epilepsy","volume":"76","author":"Chen","year":"2017","journal-title":"Epilepsy Behav"},{"issue":"1","key":"10.1016\/j.ebr.2024.100662_b0135","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s12028-021-01296-z","article-title":"Levetiracetam for seizure prophylaxis in neurocritical Care: a systematic review and meta-analysis","volume":"36","author":"Fang","year":"2022","journal-title":"Neurocrit Care"},{"issue":"2","key":"10.1016\/j.ebr.2024.100662_b0140","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.mcna.2019.11.001","article-title":"Traumatic brain injury: an overview of epidemiology, pathophysiology, and medical Management","volume":"104","author":"Capizzi","year":"2020","journal-title":"Med Clin North Am"},{"issue":"7","key":"10.1016\/j.ebr.2024.100662_b0145","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1089\/neu.2008.0586","article-title":"Classification of traumatic brain injury for targeted therapies","volume":"25","author":"Saatman","year":"2008","journal-title":"J Neurotrauma"},{"key":"10.1016\/j.ebr.2024.100662_b0150","doi-asserted-by":"crossref","first-page":"535","DOI":"10.23736\/S0390-5616.18.04532-0","article-title":"Epidemiology of severe traumatic brain injury","volume":"62","author":"Iaccarino","year":"2018","journal-title":"J Neurosurg Sci"}],"container-title":["Epilepsy & Behavior Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589986424000194?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589986424000194?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T04:22:58Z","timestamp":1778905378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589986424000194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":30,"alternative-id":["S2589986424000194"],"URL":"https:\/\/doi.org\/10.1016\/j.ebr.2024.100662","relation":{},"ISSN":["2589-9864"],"issn-type":[{"value":"2589-9864","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends of anti-seizure medication prescribing pattern in traumatic brain injury patients for the prevention of posttraumatic seizure in Taiwan","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebr.2024.100662","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100662"}}